SCD - Fulcrum Therapeutics appoints Alan A. Musso as chief financial office

August, 03 2023 09:25 AM LMP Capital and Income Fund Inc.

2023-08-03 09:25:02 ET

Clinical-stage biopharmaceutical company Fulcrum Therapeutics ( NASDAQ: FULC ) announced the appointment of Alan A. Musso as its chief financial officer, effective August 7.
Before joining Fulcrum, Alan served for several years as chief financial officer of ReViral, which was acquired by Pfizer in 2022.
He also served as the chief financial officer and treasurer at Peloton Therapeutics, where he prepared the company for an IPO until it was bought out by Merck & Co.
In April, Fulcrum had announced the departure of its then CFO Esther Rajavelu.
FULC +1.6% premarket to $3.88
Source: Press Release

For further details see:

Company Name:	LMP Capital and Income Fund Inc.
Stock Symbol:	SCD
Market:	NYSE